Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, Baltimore, Maryland.
National Institute on Aging (NIA), National Institutes of Health (NIH), Baltimore, Maryland.
JAMA Otolaryngol Head Neck Surg. 2024 Mar 1;150(3):217-225. doi: 10.1001/jamaoto.2023.4378.
IMPORTANCE: Single sensory impairment is associated with reduced functional resilience and increased mortality, though the effects of multiple sensory deficits are not known. OBJECTIVE: To investigate longitudinal associations of the type, severity, and number of sensory impairments with physical function trajectories and mortality in older adults. DESIGN, SETTING, AND PARTICIPANTS: This retrospective analysis of a longitudinal cohort study, the Health, Aging, and Body Composition (Health ABC) study, incorporated data from April 1997 to July 2013, featuring a 16-year follow-up with annual examinations and questionnaires. The cohort comprised 3075 men and women, aged 70 to 79 years at baseline, residing in Memphis, Tennessee, and Pittsburgh, Pennsylvania. All participants with complete sensory testing and covariate data at analytical baseline (year 5, 2002) were included. The data were analyzed September 1, 2022. EXPOSURES: Visual, olfactory, auditory, and touch sensory functions were assessed between 2000 and 2002. MAIN OUTCOMES: The main outcomes included physical functioning trajectories and mortality risk. Physical function was assessed longitudinally using the Health ABC physical performance battery (HABCPPB). RESULTS: A total of 1825 individuals (mean [SD] age, 77.4 [3.2] years; 957 [52%] female) were included in this study. Multivariable analysis of HABCPPB decline indicated that having 1 sensory impairment (β estimate, -0.01 [95% CI, -0.02 to -0.001]); 2 sensory impairments (β estimate, -0.01 [95% CI, -0.02 to -0.01]); 3 sensory impairments (β estimate, -0.03 [95% CI, -0.04 to -0.02]); or 4 sensory impairments (β estimate, -0.04 [95% CI, -0.05,-0.03]) was significantly associated with a steeper HABCPPB score decline in a dose-dependent manner. Adjusted Cox proportional hazards models indicated that having 1 sensory impairment (hazard ratio [HR], 1.35 [95% CI, 1.01-1.81]), 2 sensory impairments (HR, 1.58 [95% CI, 1.19-2.11]), 3 sensory impairments (HR, 1.79 [95% CI, 1.33-2.42]), or 4 sensory impairments (HR, 1.97 [95% CI, 1.39-2.79]) was significantly associated with increased mortality risk in a similarly dose-dependent manner. CONCLUSION: In this retrospective cohort study, the degree and number of multiple sensory impairments were associated with worse physical functioning and increased mortality risk. These findings represent an opportunity for further investigation into the value of screening, prevention, and treatment of sensory impairments to reduce morbidity and mortality in older adults.
重要性:单一感官障碍与功能弹性降低和死亡率增加有关,尽管多种感官缺陷的影响尚不清楚。 目的:研究老年人多种感官损伤的类型、严重程度和数量与身体功能轨迹和死亡率的纵向关联。 设计、地点和参与者:这是一项对纵向队列研究(健康、衰老和身体成分研究)的回顾性分析,纳入了 1997 年 4 月至 2013 年 7 月的数据,进行了长达 16 年的随访,每年进行一次检查和问卷调查。该队列包括 3075 名年龄在 70 至 79 岁的男性和女性,居住在田纳西州孟菲斯和宾夕法尼亚州匹兹堡。所有在分析基线(2002 年第 5 年)具有完整感官测试和协变量数据的参与者均包括在内。数据分析于 2022 年 9 月 1 日进行。 暴露情况:在 2000 年至 2002 年间评估了视觉、嗅觉、听觉和触觉感觉功能。 主要结果:主要结果包括身体功能轨迹和死亡风险。身体功能通过健康 ABC 身体表现电池(HABCPPB)进行纵向评估。 结果:共有 1825 人(平均[SD]年龄,77.4[3.2]岁;957[52%]女性)纳入本研究。HABCPPB 下降的多变量分析表明,存在 1 种感官障碍(β估计值,-0.01[95%CI,-0.02 至-0.001]);2 种感官障碍(β估计值,-0.01[95%CI,-0.02 至-0.01]);3 种感官障碍(β估计值,-0.03[95%CI,-0.04 至-0.02])或 4 种感官障碍(β估计值,-0.04[95%CI,-0.05,-0.03])与 HABCPPB 评分呈剂量依赖性的显著下降相关。调整后的 Cox 比例风险模型表明,存在 1 种感官障碍(HR,1.35[95%CI,1.01-1.81])、2 种感官障碍(HR,1.58[95%CI,1.19-2.11])、3 种感官障碍(HR,1.79[95%CI,1.33-2.42])或 4 种感官障碍(HR,1.97[95%CI,1.39-2.79])与死亡率风险增加显著相关,同样呈剂量依赖性。 结论:在这项回顾性队列研究中,多种感官损伤的程度和数量与身体功能下降和死亡率增加有关。这些发现为进一步研究筛查、预防和治疗感官障碍以降低老年人发病率和死亡率提供了机会。
JAMA Otolaryngol Head Neck Surg. 2024-3-1
Cochrane Database Syst Rev. 2020-10-19
Cochrane Database Syst Rev. 2022-8-22
JAMA Netw Open. 2025-2-3
Cochrane Database Syst Rev. 2023-1-23
Cochrane Database Syst Rev. 2022-2-24
JAMA Otolaryngol Head Neck Surg. 2025-4-10
J Gerontol A Biol Sci Med Sci. 2025-5-5
Int Forum Allergy Rhinol. 2024-10
Neuropsychol Rev. 2024-3
JAMA Otolaryngol Head Neck Surg. 2022-5-1
Chem Senses. 2021-1-1
Int Forum Allergy Rhinol. 2022-5
Aging Clin Exp Res. 2021-11
JAMA Otolaryngol Head Neck Surg. 2021-10-1
JAMA Netw Open. 2021-5-3